Show simple item record

dc.contributor.authorExecutive Board, 140en_US
dc.coverage.spatialGenevaen_US
dc.date.accessioned2018-07-24T13:09:53Z
dc.date.available2018-07-24T13:09:53Z
dc.date.issued2017
dc.identifier.govdocEB140/23 Add.1
dc.identifier.urihttps://iris.who.int/handle/10665/273266
dc.description1 p.en_US
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.subject.meshDrug Contaminationen_US
dc.subject.meshFrauden_US
dc.subject.meshDrug Industryen_US
dc.titleMember State mechanism on substandard/ spurious/falsely-labelled/falsified/ counterfeit medical products: draft decisionen_US
dc.typeGoverning body documentsen_US
who.relation.languageVersion10665/273267en_US
who.relation.languageVersion10665/273268en_US
who.relation.languageVersion10665/273269en_US
who.relation.languageVersion10665/273270en_US
who.relation.languageVersion10665/273271en_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

  • EB140
    23 January – 1 February 2017

Show simple item record